| 2025 | Effectiveness and cost-effectiveness of an individualised, progressive walking and education intervention for the prevention of low back pain recurrence in Australia (WalkBack): a randomised controlled trial | Natasha C Pocovi, Chung-Wei Christine Lin, Simon D French, Petra L Graham, Johanna M van Dongen, Jane Latimer, Dafna Merom, Anne Tiedemann, Christopher G Maher, Ornella Clavisi, Shuk Yin Kate Tong, & Mark J Hancock |
| 2024 | OPAL: The first placebo-controlled trial of opioid analgesia for acute spinal pain | Caitlin M P Jones, Richard O Day, Bart W Koes, Jane Latimer, Chris G Maher, Andrew J McLachlan, Laurent Billot, Sana Shan, Chung-Wei Christine Lin, and the OPAL Investigators and Coordinators |
| 2023 | CRISTAL: A cluster-randomised, crossover, noninferiority trial of aspirin compared to low-molecular-weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry-nested study | Verinder S. Sidhu, Thu-Lan Kelly, Nicole Pratt, Stephen E. Graves, Rachelle Buchbinder, Sam Adie, Kara Cashman, Ilana Ackerman, Durga Bastiras, Roger Brighton, Alexander W. R. Burns, Beng Hock Chong, Ornella Clavisi, Maggie Cripps, Mark Dekkers, Richard de Steiger, Michael Dixon, Andrew Ellis, Elizabeth C. Griffith, David Hale, Amber Hansen, Anthony Harris, Raphael Hau, Mark Horsley, Dugal James, Omar Khorshid, Leonard Kuo, Peter Lewis, David Lieu, Michelle Lorimer, Samuel MacDessi, Peter McCombe, Catherine McDougall, Jonathan Mulford, Justine Maree Naylor, Richard S. Page, John Radovanovic, Michael Solomon, Rami Sorial, Peter Summersell, Phong Tran, William L. Walter, Steve Webb, Chris Wilson, David Wysocki, & Ian A. Harris |
| 2022 | SHaPED: Sydney Health Partners Emergency Department trial
| Danielle M Coombs, Gustavo C Machado, Bethan Richards, Chris Needs, Rachelle Buchbinder, Ian A Harris, Kirsten Howard, Kirsten McCaffery, Laurent Billot, James Edwards, Eileen Rogan, Rochelle Facer, Qiang Li, & Christopher G Maher |
